Cargando…

Bupivacaine for Root Canal Treatment – Practitioner Behaviors and Patient Perspectives: Survey Studies

INTRODUCTION AND OBJECTIVES: Local anesthesia is essential in dentistry in providing intraoperative analgesia and anesthesia. However, knowledge related to its use for management of post-operative pain is limited. Perioperative pain management is especially important for root canal treatment (ie, en...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdogan, Ozge, Casey, Sharon M, Ruparel, Nikita B, Sigurdsson, Asgeir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820451/
https://www.ncbi.nlm.nih.gov/pubmed/35140517
http://dx.doi.org/10.2147/LRA.S339238
_version_ 1784646220450365440
author Erdogan, Ozge
Casey, Sharon M
Ruparel, Nikita B
Sigurdsson, Asgeir
author_facet Erdogan, Ozge
Casey, Sharon M
Ruparel, Nikita B
Sigurdsson, Asgeir
author_sort Erdogan, Ozge
collection PubMed
description INTRODUCTION AND OBJECTIVES: Local anesthesia is essential in dentistry in providing intraoperative analgesia and anesthesia. However, knowledge related to its use for management of post-operative pain is limited. Perioperative pain management is especially important for root canal treatment (ie, endodontic therapy), performed by endodontists. In this study, we sought to better understand endodontists’ attitudes regarding the use of long-lasting anesthetic, namely 0.5% bupivacaine HCl with 1:200,000 epinephrine, for the management of post-endodontic pain. Additionally, we aimed to understand the perspectives of dental patients about receiving longer lasting anesthesia for endodontic therapy and to determine factors that affect their anesthetic preferences within the orofacial region. METHODS: An email invitation to participate in an anonymous online survey was sent to members of the American Association of Endodontists. Also, 82 patients attending an in-person visit to an endodontic clinic were recruited to the study. RESULTS: Data from 474 endodontic practitioners and 82 patients included in analysis. Among practitioners, the majority reported to either never (33.31%) or rarely (34.84%) using bupivacaine. Most chose “I don’t think I need it” (47%) and “patient discomfort because of longer duration of soft tissue anesthesia” (30.81%) as reasons for not preferring the use of bupivacaine. Of the practitioners who reported at least rare use, most chose bupivacaine for post-operative pain management (78.02%). Conversely, 52% of patients reported that they were likely/most likely to request long-lasting anesthetics for post-operative pain control. CONCLUSION: Bupivacaine is rarely used as a post-operative pain management strategy for endodontic therapy. Specifically, bupivacaine is not preferred not because of adverse events, toxicity, or slow onset concerns, but rather, because of longer duration of soft tissue anesthesia. However, our data suggest that patients may be willing to receive long-lasting anesthesia. Further patient-centered research should investigate the use of long-lasting anesthetic agents for management of post-endodontic pain.
format Online
Article
Text
id pubmed-8820451
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-88204512022-02-08 Bupivacaine for Root Canal Treatment – Practitioner Behaviors and Patient Perspectives: Survey Studies Erdogan, Ozge Casey, Sharon M Ruparel, Nikita B Sigurdsson, Asgeir Local Reg Anesth Original Research INTRODUCTION AND OBJECTIVES: Local anesthesia is essential in dentistry in providing intraoperative analgesia and anesthesia. However, knowledge related to its use for management of post-operative pain is limited. Perioperative pain management is especially important for root canal treatment (ie, endodontic therapy), performed by endodontists. In this study, we sought to better understand endodontists’ attitudes regarding the use of long-lasting anesthetic, namely 0.5% bupivacaine HCl with 1:200,000 epinephrine, for the management of post-endodontic pain. Additionally, we aimed to understand the perspectives of dental patients about receiving longer lasting anesthesia for endodontic therapy and to determine factors that affect their anesthetic preferences within the orofacial region. METHODS: An email invitation to participate in an anonymous online survey was sent to members of the American Association of Endodontists. Also, 82 patients attending an in-person visit to an endodontic clinic were recruited to the study. RESULTS: Data from 474 endodontic practitioners and 82 patients included in analysis. Among practitioners, the majority reported to either never (33.31%) or rarely (34.84%) using bupivacaine. Most chose “I don’t think I need it” (47%) and “patient discomfort because of longer duration of soft tissue anesthesia” (30.81%) as reasons for not preferring the use of bupivacaine. Of the practitioners who reported at least rare use, most chose bupivacaine for post-operative pain management (78.02%). Conversely, 52% of patients reported that they were likely/most likely to request long-lasting anesthetics for post-operative pain control. CONCLUSION: Bupivacaine is rarely used as a post-operative pain management strategy for endodontic therapy. Specifically, bupivacaine is not preferred not because of adverse events, toxicity, or slow onset concerns, but rather, because of longer duration of soft tissue anesthesia. However, our data suggest that patients may be willing to receive long-lasting anesthesia. Further patient-centered research should investigate the use of long-lasting anesthetic agents for management of post-endodontic pain. Dove 2022-02-03 /pmc/articles/PMC8820451/ /pubmed/35140517 http://dx.doi.org/10.2147/LRA.S339238 Text en © 2022 Erdogan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Erdogan, Ozge
Casey, Sharon M
Ruparel, Nikita B
Sigurdsson, Asgeir
Bupivacaine for Root Canal Treatment – Practitioner Behaviors and Patient Perspectives: Survey Studies
title Bupivacaine for Root Canal Treatment – Practitioner Behaviors and Patient Perspectives: Survey Studies
title_full Bupivacaine for Root Canal Treatment – Practitioner Behaviors and Patient Perspectives: Survey Studies
title_fullStr Bupivacaine for Root Canal Treatment – Practitioner Behaviors and Patient Perspectives: Survey Studies
title_full_unstemmed Bupivacaine for Root Canal Treatment – Practitioner Behaviors and Patient Perspectives: Survey Studies
title_short Bupivacaine for Root Canal Treatment – Practitioner Behaviors and Patient Perspectives: Survey Studies
title_sort bupivacaine for root canal treatment – practitioner behaviors and patient perspectives: survey studies
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820451/
https://www.ncbi.nlm.nih.gov/pubmed/35140517
http://dx.doi.org/10.2147/LRA.S339238
work_keys_str_mv AT erdoganozge bupivacaineforrootcanaltreatmentpractitionerbehaviorsandpatientperspectivessurveystudies
AT caseysharonm bupivacaineforrootcanaltreatmentpractitionerbehaviorsandpatientperspectivessurveystudies
AT ruparelnikitab bupivacaineforrootcanaltreatmentpractitionerbehaviorsandpatientperspectivessurveystudies
AT sigurdssonasgeir bupivacaineforrootcanaltreatmentpractitionerbehaviorsandpatientperspectivessurveystudies